Posts In: Gubba Pharma In E News

Good News For Cancer Patients in India Cell-Therapy To Go Cheaper

In the US, the treatment of cancer of the blood cells- leukaemia by CAR T-cell therapy costs $800,000-$900,000 (which is around Rs 6-7 crore)Cancer patients...

Continue Reading

Granules India to double its R&D efforts to develop innovative products

In the last financial year, the company had spent ₹143 crore on R&D and set up its state-of-the-art centre, where about 150 scientists are working.Hyderabad...

Continue Reading

GPN::MAY-JUNE 2022::PDF

Continue Reading

Lifespan becomes first nodal testing agency of Ayush in Telangana

Lifespan Private Limited has received an approval from the Department of Ayush, government of Telangana for carrying out tests for the identity, purity, quality and...

Continue Reading

Coming Soon: Research-linked Incentive Scheme to Rejuvenate Global Image of Indian Pharma Market

With an aim of improving India’s position in the global pharmaceuticals market on the innovation index, the Narendra Modi government is preparing to launch a...

Continue Reading

FTCCI Excellence Award Presented to Converge Biotech Private Limited, Hyderabad in recognition of EXCELLENCE IN PRODUCT INNOVATION (MICRO AND SMALL ENTERPRISE)

Converge Biotech Private Limited, Hyderabad started by Mr. Arunkumar Bijjala in the year 2015, had more than 2 decades of experience working in reputed Pharmaceutical...

Continue Reading

Dr Reddy’s Labs acquires injectable product portfolio from Eton Pharma

Hyderabad-based Dr Reddy’s Laboratories has acquired a portfolio of branded and generic injectable products from US-based Eton Pharmaceuticals.The portfolio includes the Biorphen (phenylephrine hydrocholoride) Injection...

Continue Reading

Biological E gets WHO nod to be addl facility for production of J&J vaccine

India’s first indigenously developed RBD protein subunit vaccine, Biological E’s Corbevax, is currently being used to inoculate children in the age group of 12 to...

Continue Reading

Cipla to hike stake in GoApptiv

The drug major on the other day said that it has entered into definitive agreements for further investment of Rs 25.90 crore in digital tech...

Continue Reading